Beltran, Eric John N.

HRN: 13-29-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
12/19/2023
12/26/2023
PO
5ml
Every 12 Hours
Empiric
Waiting Final Action 
12/19/2023
CEFALEXIN 250MG/5ML, 60ML SUSPENSION (BOT)
12/19/2023
12/26/2023
PO
5ml
Every 8hours
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: